PI
Pharmstandard International Portfolio holdings
AUM
$29M
1-Year Est. Return
2.12%
1 Year Est. Return
+2.12%
AUM
$24.9M
AUM Growth
-$14.7M
(-37%)
Holding
5
Top Buys
No buys this quarter
Top Sells
| 1 | +$2.07M | |
| 2 | +$1.56M | |
| 3 | +$743K | |
| 4 |
Protara Therapeutics
TARA
|
+$147K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALNA
1
DELISTED
Allena Pharmaceuticals
ALNA
| $11.4M | 45.89% |
878,131
-159,136
|
|
||
2
Protagonist Therapeutics
PTGX
$4.96B
| $5.04M | 20.23% |
750,632
-231,638
|
|
||
|
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $4.33M | 17.36% |
565,063
-97,000
|
|
||
|
4
Protara Therapeutics
TARA
$166M
| $3.94M | 15.8% |
40,195
-1,503
|
|
||
|
ARGS
5
DELISTED
Argos Therapeutics, Inc.
ARGS
| $136K | 0.55% |
826,153
|
|